Featured Jobs
|
Regional Vice President, Sales MAP Retirement USA LLC
|
|
ESOP Administration Consultant Blue Ridge Associates
|
|
Combo Retirement Plan Administrator Strongpoint Partners
|
|
Mergers & Acquisition Specialist Compass
|
|
Relationship Manager for Defined Benefit/Cash Balance Plans Daybright Financial
|
|
Retirement Plan Consultants
|
|
Strongpoint Partners
|
|
July Business Services
|
|
Retirement Plan Administration Consultant Blue Ridge Associates
|
|
Compass
|
|
Cash Balance/ Defined Benefit Plan Administrator Steidle Pension Solutions, LLC
|
|
DC Retirement Plan Administrator Michigan Pension & Actuarial Services, LLC
|
|
Anchor 3(16) Fiduciary Solutions
|
|
Managing Director - Operations, Benefits Daybright Financial
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
|
Eli Lilly Strikes Back Against Pharmacy Compounders and Telehealth Platforms
Holland & Knight 
June 13, 2025 "Telehealth companies selling compounded drugs are making modest inroads into the market for popular weight loss drugs that big pharma spent decades and billions of dollars to develop and bring to market. The compounded products, with fewer barriers to entry, are reaching a broader consumer market than U.S. Food and Drug Administration (FDA)-approved glucagon-like peptide-1 (GLP-1) products, and at least one brand pharma player -- Eli Lilly and Company (Lilly) -- is turning the courts to reverse the trend." MORE >> |
| Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
| An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |